Why CVS Health Corp. (CVS) stock moved
CVS Health Corp. (CVS) shares rose 0.1% to $107.61 as of July 21, 2026, a slight gain from the prior close of $107.47. BestStocks flagged the session as a major change for CVS. No single company-specific catalyst was confirmed, so the move reads as a company-specific move. Below, we break down what changed for CVS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CVS climbed 0.1% to $107.61
CVS Health Corp. (CVS) moved +0.13% from $107.47 to $107.61 on 2026-07-20. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to be a continuation of a technical trend, with CVS reaching a new 30-day high on below-average volume (0.7x the 5-day average). Monitor whether CVS sustains the new high on higher volume, or if the move reverts without broader market support.
What it means for CVS Health Corp. investors
For CVS Health Corp. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.1% session move; CVS Health Corp. (CVS) moved +0.91% from $106.50 to $107.47 on 2026-07-17. Weighing against that: CVS Health Corp. (CVS) moved -2.52% from $104.72 to $102.08 on July 6, 2026; New SEC filing — review for material disclosures. Because the move outpaced peers, it looks driven by CVS-specific developments rather than a broad sector rotation. Wall Street's consensus price target sits at $106.57, implying -1.0% downside from $107.61. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
CVS price reaction
CVS last traded at $107.61, up $0.14 (+0.13%) from the previous close of $107.47. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Its healthcare peer group moved a median -1.2% over the same stretch, leaving CVS ahead of the group by 1.3 points. Over the past month the stock has ranged between $101.30 and $107.61, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on CVS Health Corp. (CVS)
The consensus analyst price target on CVS Health Corp. (CVS) is $106.57, 1.0% below the recent $107.61. Over the past 90 days analysts logged 0 upgrades, 20 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CVS line up.
The bullish case
- The Street's most bullish target is $123.00 (+14.3%).
- Positive 0.1% session move.
- CVS Health Corp. (CVS) moved +0.91% from $106.50 to $107.47 on 2026-07-17.
The bearish case
- The consensus analyst price target of $106.57 sits 1.0% below the recent $107.61, so the average target sees limited room to run.
- The most bearish analyst target is $90.00 (-16.4%).
- CVS Health Corp. (CVS) moved -2.52% from $104.72 to $102.08 on July 6, 2026.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CVS
Frequently asked questions about CVS
Why did CVS Health Corp. (CVS) stock move?
CVS rose 0.1% to $107.61. No single company-specific catalyst was confirmed during the move window, and it looks like a company-specific move.
How much did CVS stock rise?
CVS gained 0.13% ($0.14) versus the prior close of $107.47, last trading at $107.61 on 0.6× average volume.
When is CVS Health Corp.'s next earnings date?
CVS's next earnings report is estimated for 2026-08-05 — about 15 days away.
What is the analyst price target for CVS?
The consensus analyst price target for CVS is $106.57, about 1.0% below the current $107.61. Over the past 90 days, analysts recorded 0 upgrades, 20 maintains, and 0 downgrades.
Is the CVS move company-specific or sector-wide?
BestStocks classifies it as a company-specific move: the peer group moved a median -1.2% against CVS's +0.1%. CVS ranks top 1 of 7 peers.
How BestStocks tracks CVS
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CVS-specific materiality thresholds, triggering an evidence check. It draws on 11 tracked change events for CVS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.